Scholar : Acta Oncologica, Volume 56, Issue 7, July 2017 is now available online on Taylor & Francis Online

The online platform for Taylor & Francis Online content Acta Oncologica, Volume 56, Issue 7, July 2017 is now available online on Taylor & Francis Online. This new issue contains the following articles: REVIEW Cocktail without hangover: in search for the optimal chemotherapy in the combined management of non-operable esophageal carcinomas Bianca So, Loredana G. Marcu, Ian Olver, Raghu Gowda & Eva Bezak Pages: 899-908 | DOI: 10.1080/0284186X.2017.1307518 ORIGINAL ARTICLES: PHASE I STUDY Gene therapy for patients with advanced solid tumors: a phase I study using gene electrotransfer to muscle with the integrin inhibitor plasmid AMEP Iben Spanggaard, Karin Dahlstroem, Line Laessoee, Rasmus Hvass Hansen, Helle Hjorth Johannesen, Helle Westergren Hendel, Céline Bouquet, Pierre Attali & Julie Gehl Pages: 909-916 | DOI: 10.1080/0284186X.2017.1315171 ORIGINAL ARTICLES: GASTROINTESTINAL TUMORS Challenges in evaluation of screening for gastric cancer among men based on nonrandomized design | Ilkka Vohlonen, Matti Härkönen, Nea Malila, Eero Pukkala, Pentti Sipponen, Veli Koistinen & Matti Hakama Pages: 917-922 | DOI: 10.1080/0284186X.2016.1278304 Addition of MRI for CT-based pancreatic tumor delineation: a feasibility study Oliver J. Gurney-Champion, Eva Versteijne, Astrid van der Horst, Eelco Lens, Heidi Rütten, Hanne D. Heerkens, Gabriel M. R. M. Paardekooper, Maaike Berbee, Coen R. N. Rasch, Jaap Stoker, Marc R. W. Engelbrecht, Marcel van Herk, Aart J. Nederveen, Remy Klaassen, Hanneke W. M. van Laarhoven, Geertjan van Tienhoven & Arjan Bel Pages: 923-930 | DOI: 10.1080/0284186X.2017.1304654 ORIGINAL ARTICLES: THORACIC ONCOLOGY Lung cancer in never-smokers – what are the differences? Margarida Dias, Rita Linhas, Sérgio Campainha, Sara Conde & Ana Barroso Pages: 931-935 | DOI: 10.1080/0284186X.2017.1287944 Lobectomy for non-small cell lung carcinoma: a nationwide study of short- and long-term survival G. N. Oskarsdottir, H. Halldorsson, M. I. Sigurdsson, B. M. Fridriksson, K. Baldvinsson, A. W. Orrason, S. Jonsson, M. Planck & T. Gudbjartsson Pages: 936-942 | DOI: 10.1080/0284186X.2017.1304652 Lung cancer guidelines in Sweden, Denmark, Norway and Finland: a comparison Niels Lyhne Christensen, Antti Jekunen, Sebastian Heinonen, Susanne Oksbjerg Dalton & Torben Riis Rasmussen Pages: 943-948 | DOI: 10.1080/0284186X.2017.1315172 The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study Jonas Nilsson, Anders Berglund, Stefan Bergström, Michael Bergqvist & Mats Lambe Pages: 949-956 | DOI: 10.1080/0284186X.2017.1324213 Long-term outcomes of intensity-modulated radiotherapy following extra-pleural pneumonectomy for malignant pleural mesothelioma Yukinori Matsuo, Keiko Shibuya, Kenichi Okubo, Nami Ueki, Akihiro Aoyama, Makoto Sonobe, Mitsuhiro Nakamura, Takashi Mizowaki, Hiroshi Date & Masahiro Hiraoka Pages: 957-962 | DOI: 10.1080/0284186X.2017.1279749 ORIGINAL ARTICLES: PROSTATE CANCER Five-year outcomes from a prospective trial of image-guided accelerated hypofractionated proton therapy for prostate cancer | Randal H. Henderson, Curtis Bryant, Bradford S. Hoppe, R. Charles Nichols, William M. Mendenhall, Stella Flampouri, Zhong Su, Zuofeng Li, Christopher G. Morris & Nancy P. Mendenhall Pages: 963-970 | DOI: 10.1080/0284186X.2017.1287946 Stage-specific mortality and survival trends of prostate cancer patients in Finland before and after introduction of PSA Heikki A. Seikkula, Antti J. Kaipia, Matti E. Rantanen, Janne M. Pitkäniemi, Nea K. Malila & Peter J. Boström Pages: 971-977 | DOI: 10.1080/0284186X.2017.1288298 Hypofractionated stereotactic body radiotherapy for localized prostate cancer – first Nordic clinical experience Kristiina Koskela, Jan-Erik Palmgren, Janne Heikkilä, Heli Virsunen, Liisa Sailas, Päivi Auvinen, Jan Seppälä & Vesa Kataja Pages: 978-983 | DOI: 10.1080/0284186X.2017.1288923 How badly did it hit? Self-assessed emotional shock upon prostate cancer diagnosis and psychological well-being: a follow-up at 3, 12, and 24 months after surgery Karin Stinesen Kollberg, Ulrica Wilderäng, Thordis Thorsteinsdottir, Jonas Hugosson, Peter Wiklund, Anders Bjartell, Stefan Carlsson, Johan Stranne, Eva Haglind & Gunnar Steineck Pages: 984-990 | DOI: 10.1080/0284186X.2017.1300320 ORIGINAL ARTICLES: ENDOCRINE TUMORS A nationwide study on parathyroid carcinoma Eeva M. Ryhänen, Helena Leijon, Saara Metso, Eija Eloranta, Pirkko Korsoff, Petteri Ahtiainen, Päivi Kekäläinen, Marjo Tamminen, Raija Ristamäki, Otto Knutar, Eliisa Löyttyniemi, Leo Niskanen, Mika Väisänen, Ilkka Heiskanen, Matti J. Välimäki, Markku Laakso, Caj Haglund, Johanna Arola & Camilla Schalin-Jäntti Pages: 991-1003 | DOI: 10.1080/0284186X.2017.1306103 ORIGINAL ARTICLES: SARCOMA Follow-up after initial surgical treatment of soft tissue sarcomas in the extremities and trunk wall Thea Bechmann Hovgaard, Tine Nymark, Ole Skov & Michael Mørk Petersen Pages: 1004-1012 | DOI: 10.1080/0284186X.2017.1299937 Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study Robin J. Young, Saskia Litière, Michela Lia, Pancras C. W. Hogendoorn, Cyril Fisher, Gunhild Mechtersheimer, Søren Daugaard, Raf Sciot, Françoise Collin, Christina Messiou, Viktor Grünwald, Alessandro Gronchi, Winette van der Graaf, Eva Wardelmann & Ian Judson Pages: 1013-1020 | DOI: 10.1080/0284186X.2017.1315173 LETTERS TO THE EDITOR Accelerated or conventional whole brain irradiation of malignant melanoma Ragnar Hultborn, Johanna Sand, Sara Kinhult, Lotta Lundgren, Ulrika Stierner, Ingela Turesson & Per Albertsson Pages: 1021-1023 | DOI: 10.1080/0284186X.2016.1275777 Tolerability of the oral fluoropyrimidine S-1 after hand-foot syndrome-related discontinuation of capecitabine in western cancer patients J. J. M. Kwakman, A. Baars, H. Boot, J. F. M. Pruijt, S. B. Winther, P. Pfeiffer & C. J. A. Punt Pages: 1023-1026 | DOI: 10.1080/0284186X.2016.1278459 Distress in patients with cancer – on the need to distinguish between adaptive and maladaptive emotional responses | Joost Dekker, Annemarie Braamse, Claudia Schuurhuizen, Aartjan T. F. Beekman, Myra van Linde, Mirjam A. G. Sprangers & Henk M. Verheul Pages: 1026-1029 | DOI: 10.1080/0284186X.2017.1280848 Publish your research with us! Growth Factors (Impact Factor: 2.043) is now inviting submissions. To update which email alerts you receive, manage your alerts within the My Account area. You can also unsubscribe from this alert with one click. If you need any further help, please contact us at support@tandfonline.com Please do not reply to this email. To ensure that you receive your alerts and information from Taylor & Francis Online, please add "alerts@tandfonline.com" and "info@tandfonline.com" to your safe senders list. Taylor & Francis, an Informa business. Taylor & Francis is a trading name of Informa UK Limited, registered in England under no. 1072954. Registered office: 5 Howick Place, London, SW1P 1WG.